Ischemic Stroke - Pipeline Review, H2 2015 Now Available at iData Insights Ischemic Stroke - Pipeline Review, H2 2015 Summary Global Markets Direct s, Ischemic Stroke - Pipeline Review, H2 2015 , provides an overview of the Ischemic Stroke s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ischemic Stroke, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ischemic Stroke and special features on late-stage and discontinued projects. Global Markets Direct s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Ischemic Stroke - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Ischemic Stroke and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Ischemic Stroke products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Ischemic Stroke pipeline on the basis of target, MoA, route of administration and molecule type Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Ischemic Stroke - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Ischemic Stroke pipeline depth and focus of Indication therapeutics - Develop and design inlicensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Browse Complete Report with TOC @ http://www.idatainsights.com/reports-landingpage.php?id=124188/ischemic-stroke-pipeline-review-h2-2015 To Get Sample Copy of Report visit @ http://www.idatainsights.com/reports-landingpage.php?id=124188/ischemic-stroke-pipeline-review-h2-2015 Table of Contents Table of Contents 2 List of Tables 6 List of Figures 8 Introduction 9 Global Markets Direct Report Coverage 9 Ischemic Stroke Overview
1
10 Therapeutics Development 11 Pipeline Products for Ischemic Stroke - Overview 11 Pipeline Products for Ischemic Stroke - Comparative Analysis 12 Ischemic Stroke - Therapeutics under Development by Companies 13 Ischemic Stroke - Therapeutics under Investigation by Universities/Institutes 18 Ischemic Stroke - Pipeline Products Glance 19 Late Stage Products 19 Clinical Stage Products 20 Early Stage Products 21 Ischemic Stroke - Products under Development by Companies 22 Ischemic Stroke - Products under Investigation by Universities/Institutes 27 Ischemic Stroke - Companies Involved in Therapeutics Development 28 AB Science SA 28 Acticor Biotech 29 advanceCor GmbH 30 Angion Biomedica Corp. 31 AstraZeneca Plc 32 Athersys, Inc. 33 biOasis Technologies Inc. 34 Biogen, Inc. 35 BioTime, Inc. 36 D-Pharm Ltd. 37 Daiichi Sankyo Company, Limited 38 DiaMedica Inc. 39 Digna Biotech, S.L. 40 Genervon Biopharmaceuticals, LLC 41 Glialogix, Inc. 42 Glucox Biotech AB 43 Grifols, S.A. 44 Huons Co., Ltd. 45 International Stem Cell Corporation 46 JN-International Medical Corporation 47 Laboratoires Pierre Fabre SA 48 Lumosa Therapeutics Co., Ltd. 49 MediaPharma s.r.l. 50 Mitsubishi Tanabe Pharma Corporation 51 Neuralstem, Inc. 52 Neurotec Pharma SL
2
53 NeuroVive Pharmaceutical AB 54 NoNO, Inc. 55 Panacea Pharmaceuticals, Inc. 56 Pharmicell Co., Ltd. 57 PhytoHealth Corporation 58 Remedy Pharmaceuticals, Inc. 59 ReNeuron Group Plc 60 SanBio, Inc. 61 Saneron CCEL Therapeutics, Inc. 62 Simcere Pharmaceutical Group 63 Stemedica Cell Technologies, Inc. 64 SynZyme Technologies, LLC 65 The International Biotechnology Center (IBC) Generium 66 TikoMed AB 67 vasopharm GmbH 68 Vicore Pharma AB 69 Virogenomics, Inc. 70 Ischemic Stroke - Therapeutics Assessment 71 Assessment by Monotherapy Products 71 Assessment by Target 72 Assessment by Mechanism of Action 76 Assessment by Route of Administration 79 Assessment by Molecule Type 81 Drug Profiles 83 3K3A-APC - Drug Profile 83 ACT-017 - Drug Profile 85 alteplase biosimilar - Drug Profile 86 BB-3 - Drug Profile 87 BSc-2118 - Drug Profile 90 C-21 - Drug Profile 91 Cerecellgram-Stroke - Drug Profile 93 CNB-001 - Drug Profile 94 DB-017 - Drug Profile 96 DM-199 - Drug Profile
3
97 Drugs to Inhibit Sir2 Protein for Ischemic Stroke and Myocardial Infarction - Drug Profile 98 DS-1040 - Drug Profile 99 GLX-1112 - Drug Profile 100 glyburide - Drug Profile 101 GM-602 - Drug Profile 103 GXNPC-1 - Drug Profile 104 HBN-1 - Drug Profile 105 HU-010 - Drug Profile 106 Human Plasmin - Drug Profile 107 Human Umbilical Cord Blood Cell Therapy for Neurological and Cardiovascular Diseases - Drug Profile 109 ISC-hpNSC - Drug Profile 112 levomilnacipran hydrochloride ER - Drug Profile 114 LT-3001 - Drug Profile 116 Lysimab - Drug Profile 117 masitinib - Drug Profile 118 Memantine Nitrone - Drug Profile 123 Mesenchymal Stem Cells - Drug Profile 124 MP124 - Drug Profile 126 MPHE-001A - Drug Profile 127 MTfp-siRNA - Drug Profile 128 MultiStem - Drug Profile 129 NA-1 - Drug Profile 133 natalizumab - Drug Profile 135 NSI-566 - Drug Profile 137 NTKC-005 - Drug Profile 139 NVP-014 - Drug Profile 140 NVX-208 - Drug Profile 141 PAN-811 - Drug Profile 142 Peptide to Agonize GHSR-1a for Sepsis, Acute Radiation Syndrome and Acute Ischemic Stroke - Drug Profile 144 PHN-014 - Drug Profile 146 Pinocembrin - Drug Profile 147 Polyglactin 370 for Ischemic Stroke - Drug Profile 148 PR-15 - Drug Profile 149 prasugrel hydrochloride - Drug Profile
4
151 Protein for Ischemic Stroke - Drug Profile 154 Protein for Ischemic Stroke - Drug Profile 155 Protein for Ischemic Stroke - Drug Profile 156 Recombinant Peptide for Ischemic Stroke - Drug Profile 157 Recombinant Plasmin - Drug Profile 159 Recombinant Protein for Ischemic Cerebral Stroke and Myocardial Ischemia - Drug Profile 160 Recombinant Proteins to Inhibit Serine Protease for Thrombosis, Ischemic Stroke and Atherosclerosis - Drug Profile 161 ReN-001 - Drug Profile 162 RTL-551 - Drug Profile 164 SB-623 - Drug Profile 166 SIM-071201 - Drug Profile 168 Small Molecule to Activate Epsilon PKC for Ischemic Stroke - Drug Profile 169 Small Molecule to Block Sodium Channels for Ischemic Stroke - Drug Profile 170 Small Molecule-1 to Inhibit NOX-4 for Acute Ischemic Stroke - Drug Profile 171 Small Molecule-2 to Inhibit NOX-4 for Acute Ischemic Stroke - Drug Profile 172 Small Molecules to Activate Glutathione Peroxidase for Ischemic Stroke and Liver Failure - Drug Profile 173 Small Molecules to Block Sodium and hERG Channel for Ischemic Stroke - Drug Profile 174 Small Molecules to Inhibit CaMKII for Ischemic Stroke - Drug Profile 175 Small Molecules to Inhibit Kinase for Ischemic Stroke - Drug Profile 176 SMTP-7 - Drug Profile 177 StromAb - Drug Profile 178 T-33 - Drug Profile 180 TF-0023 - Drug Profile 181 THR-18 - Drug Profile 182 ticagrelor - Drug Profile 183 TM-700 - Drug Profile 187 TPAi-14 - Drug Profile 188 TPAi-23 - Drug Profile 189 TS-01 - Drug Profile 190 TXA-127 - Drug Profile 191 TXA-302 - Drug Profile 193 UCCB-01144 - Drug Profile 195 Vaccine to Target NMDAR1 for Ischemic Stroke - Drug Profile 196 VACNO - Drug Profile
5
197 VAS-2870 - Drug Profile 198 Ischemic Stroke - Recent Pipeline Updates 199 Ischemic Stroke - Dormant Projects 255 Ischemic Stroke - Discontinued Products 260 Ischemic Stroke - Product Development Milestones 263 Featured News & Press Releases 263 Appendix 270 Methodology 270 Coverage 270 Secondary Research 270 Primary Research 270 Expert Panel Validation 270 Contact Us 270 Disclaimer Read More @ http://www.idatainsights.com/reports-landing-page.php?id=124188/ischemic-stroke-pipeline-reviewh2-2015 About Us: iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.
Contact Us: iData Insights Tel: 1-866-237-2965 Web: http://www.idatainsights.com Email: info@idatainsights.com
About iData Insights We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects.
6